Global mHealth Monitoring and Diagnostic Medical Devices Market to Exhibit Growth at 9.4% CAGR till 2019

mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices such as mobile phones, tablets, computers and PDAs for health services and information. mHealth helps to reduce healthcare expenditure by limiting the number of hospital visits and also reduces re-admissions. In developing countries, mobile connectivity with healthcare professionals helps in decreasing the bridge between healthcare professionals and patients. Increasing geriatric population coupled with rising prevalence of chronic diseases are the key factors supporting the growth of the mHealth monitoring and diagnostic devices market globally. 

The global mHealth monitoring and diagnostic medical devices market is growing at a CAGR of 43.3% from 2013 to 2019. The market, worth US$0.65 billion in 2012, will be worth US$8.03 billion by 2019. A report released by Transparency Market (TMR), titled “mHealth Monitoring And Diagnostic Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019”, examines various aspects of this market and is for sale on TMR’s website.According to report, the rising prevalence of diabetes and other chronic illnesses is the primary growth factor for the global mHealth monitoring and diagnostic medical devices market. The market’s growth is also influenced by the growing geriatric population across the world.

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2018

The report also cites statistics that explains the rapid growth of the global mHealth monitoring and diagnostic medical devices market. It includes a statement from the Center for Technology and Aging, which states that there can be savings of nearly US$200 billion within the coming 25 years in medical expenses, due to the products and services provided by mHealth market players.Another citation is a statement by the International Diabetes Federation that the number of diabetics in the world in 2013 was 392 million and could easily increase to 592 million by 2035. This rise in the number of diabetics, as per the report, is one of the greatest growth factors of the global mHealth monitoring and diagnostic medical devices market. This goes along with the rapid growth rate of the glucose monitors segment.

Modern factors that could drive the global mHealth monitoring and diagnostic medical devices market include the use of smartphones in tandem with the current advancements in the mHealth market. The segment of multi-parameter monitoring devices could be a possible favored target for this level of innovation, allowing it to gain substantial market share in the near future.The top companies in the global mHealth monitoring and diagnostic medical devices market discussed in the report include Omron Healthcare, Medtronic Inc., LifeWatch AG, Johnson & Johnson, F. Hoffmann La-Roche Ltd., DexCom, Inc., Dräger AG, Boston Scientific Corporation, Bayer HealthCare AG, BioTelemetry Inc., AT&T, Inc., and Masimo Corporation.

Browse Report: http://www.transparencymarketresearch.com/mHealth-monitoring-diagnostic-medical-devices.html 

Live Cell Imaging (LCI) Market will Increase Strongly Through 2023

Live cell imaging (LCI) is changing the approach in which biologists study proteins, cells, molecular interactions and a multitude of processes. LCI techniques are allowing the scientists to monitor cellular processes and internal structures in real time, and over time. Understanding dynamic processes and cellular structures is serious to addressing several queries of cell biology. The observation of vital changes is offering in-depth understanding into the operations of a cell than an image provided by imaging studies of fixed cells. Additionally, meanwhile live cell imaging is less liable to trial artifacts; it generally offers more valid and appropriate information than does fixed cell microscopy. The study of living cells through pictures developed from imaging systems such as microscopes and screening system that is high content is termed as live cell imaging. LCI used by the scientists to give an enhanced view of biological function through the study of cellular dynamics. This information is vital in research regions including genetics, in drug discovery, neurobiology, immunology, cytology, and microbiology.

The Global Live Cell Imaging market segmented, based on products, technologies, applications, and regions. Based on products classification of LCI is equipment, software, and consumables. The further classification of equipment is microscopes, image capturing devices, and standalones system and cell analyzers. Currently microscope has the largest share in the equipment. Consumable differentiation is as reagents, media, and assay kits. The assay kit has accounted for the major share in consumable market. Technology market is segmented into Fluorescence recovery after photo bleaching (FRAP), Forster resonance energy transfer (FRET), Total internal reflection fluorescence microscopy (TIRF), Time-domain Fluorescence Lifetime Imaging Microscopy (TD-FLIM), Photo activated localization microscopy (PALM) and multiphoton excitation microscopy (MPE).Based on application it is classified as chemotaxis, angiogenesis, migration or wound healing and cell culture under flow.

The high content screening technology in drug discovery, large funding by the government for cell based research and the increasing incidences of cancer are the factors responsible to drive the market for LCI. However, the shortage of skilled professional and huge cost of high content screening system can hinder the growth of LCI market.

Some of the major players in the LCI market are Carl Zeiss AG, Leica Microsystems, Molecular Devices, LCC, Nikon Corporation, PerkinElmer, Inc. Becton, Dickinson and Company, GE Healthcare, Sigma-Aldrich Corporation, and Thermo Fisher Scientific, Inc.

Get Full Report: http://www.transparencymarketresearch.com/live-cell-imaging-market.html

Internal Fixation Devices to Remain Keystone of Global Spinal Trauma Devices Market

Spinal trauma devices stabilize the posterior area of spine while allowing motion and limiting the compression to the affected area of the spine. The demand for spinal trauma devices is perpetually is perpetually growing due to increasing incidence of road accidents, falls, and violence leading to traumatic injuries. Moreover, technological advancements, growing medical awareness, and introduction of biocompatible devices would propel growth of spinal trauma devices market.

The spinal trauma devices are categorized on the basis of device type: internal fixation devices, and external fixation devices. The application of these devices is mainly based on the type of injury. Internal fixation devices involve surgical implementation of implants to fix broken spinal bones. External fixation devices are majorly used to stabilize the fractured spinal bone.

Get a sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7613

The internal fixation devices dominated the global spinal trauma devices market in 2014. The internal devices segment has been further sub-segmented into plates and screws, rods and pins and bone grafts. The plates and screws segment held the largest share of the internal fixation devices in 2014 due to shifting trend towards the application of bioresorbable plates and screws as internal fixation for spinal traumas. Bioresorbable implants are resorbed over a period of time and hence eliminates the need for a second surgical procedure. While lowered pain associated and minimum immunological rejection from bone grafts, coupled with development of novel therapies by major players has lead the bone grafts segment to witness the highest growth rate during the forecast period. The major factors driving the internal fixation devices segment include durability of the devices, cost-effectiveness coupled with product advancements. Moreover, internal fixation devices require comparatively less postoperative follow-up than external fixators boosting the demand for internal fixation devices further.

The external fixation devices segment is anticipated to witness a sluggish growth rate during the forecast period. These devices include Ilizarov devices, spinal cord stimulators, robotic exoskeletons, spinal braces, collars and halo vests. Ilizarov devices are the most significant type and widely used external fixation device majorly used for bone lengthening.

The global spinal trauma devices market exhibits intense competition among the existing players. The market is fragmented, characterized by the presence of both established as well as emerging companies. Major players operating in the spinal trauma devices market are Medtronic plc, DePuy Synthes, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Arthrex, Inc., B. Braun Melsungen AG, CONMED Corporation, Smith & Nephew plc, Zimmer Biomet, Orthofix International, Spinal Technology, Inc., and ReWalk Robotics.

Get our expert opinion: http://www.transparencymarketresearch.com/spinal-trauma-devices-market.html

Demand for Cosmetic Surgery Products will Grow rapidly by 2029

Cosmetic surgery is a kind of plastic surgery that aims to improve or enhance the aesthetic appearance of an individual. Cosmetic surgery can be performed on any part of the body, neck and face. Cosmetic surgery products are manufactured by using natural ingredients, chemicals and minerals. Technological advancement in the manufacturing of cosmetic surgery products is one of the driving factors for the cosmetic surgery products market. However, the economic improvement in the emerging countries such as China, India, Brazil and Dubai has further increased the utilization of cosmetic surgery products, as consumers have more disposable income.

One of the biggest pros towards getting cosmetic surgery is that, with the enhancement of one’s appearance, an individual’s self-esteem and confidence level is improved. Conversely, one of the biggest cons of cosmetic surgery is that there are always risks of complications, which can be devastating.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2359

The generally used cosmetic surgery products are as follows:

• Injectables
• Botulinum toxin
• Collagen
• Hyaluronic acid
• Implants
• Breast implants
• Chin and cheek implants
• Lip implants
• Equipment
• Dermal resurfacing lasers
• Hair removal lasers
• Liposuction equipment
• Microdermabrators
• Light based systems

Some of the surgical and non-surgical procedures used for cosmetic enhancement are as follows:

• Surgical procedures
• Liposuction
• Eyelid surgery
• Nose surgery
• Breast augmentation
• Tummy tuck
• Non-surgical procedures
• Botox
• Hair removal
• Photo rejuvenation
• Hyaluronic Acid
• Hair removal

From the geographical perspective, North America accounts for the largest market share of cosmetic surgery products owing to the rising aging population and high adoption rate of advance aesthetic products. According to the American Society for Aesthetic Plastic Surgery (ASAPS) in 2012, 43 percent of the total population of Generation X those range in age between 31 and 45, underwent aesthetic procedures to retain their youth and beauty. Additionally, the ASAPS also reported that in 2013, more than 11,000,000 cosmetic non-surgical as well as surgical procedures were performed by board-certified dermatologists and plastic surgeons in the U.S. However, other regions such as Asia-Pacific, Middle East and Latin America are expected to be the potential markets in the near future. Due to the widespread awareness about aesthetic products, these regions are estimated to be the potential markets.

The cosmetic surgery products market has witnessed a significant growth in the last few years. The

major factors propelling the growth of the cosmetic surgery products market are increasing aging population coupled with growing demand for retaining youth and beauty among population. Moreover, other factors such as expanding media exposure, faster results and overall reluctance among population to age gracefully are also contributing to the growth of the cosmetic surgery products market. Furthermore, increased disposable incomes and high awareness among population along with high adoption rate for innovative cosmetic products are also driving the growth of this market. However, market-restraining factors such as adverse effects, high cost involved in the development of cosmetic products and stringent regulatory approvals; are some of the restraints that can hinder the market of cosmetic surgery products globally.

Currently, the global cosmetic surgery products market is highly competitive owing to the involvement of many established players. Some of the key players in the global cosmetic surgery products market are Allergan, Inc., Alma Lasers, Ltd., Cutera, Inc., IRIDEX Corporation, Johnson & Johnson, Lumenis Ltd., Genesis Biosystems, Inc., Merz Aesthetics, Inc., Sanofi S.A., Smith & Nephew plc, Syneron Medical Ltd. and Valeant Pharmaceuticals International, Inc.